# Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

> **NCT00005825** · PHASE2 · UNKNOWN · sponsor: **Raghu Nandan, M.D., Inc**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** mitomycin C
- **DRUG:** tretinoin
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00005825
- **Lead sponsor:** Raghu Nandan, M.D., Inc
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005825, "Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00005825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*